John Srivisal
Analyst · Deutsche Bank
Thank you, John. Turning to Slide 6. We generated revenue of $774 million, an increase of 9% compared to the prior year or 13% sequentially, driven by higher revenue from both TiO2 and zircon. Income from operations was $41 million in the quarter and we reported a net loss of $9 million. While our profit before tax was $2 million, our tax expense was $11 million in the quarter. This was due to the fact that we generated higher-than-expected earnings in jurisdictions where we pay taxes, driven mainly by higher zircon sales. As a result, our adjusted diluted earnings per share was a loss of $0.05. As John previously mentioned, our adjusted EBITDA in the quarter was $131 million, and our adjusted EBITDA margin was approximately 17%. Free cash flow was a use of $105 million, of which $76 million was from capital expenditures. Now let's move to Slide 7 for a view of our commercial performance. As John mentioned, the recovery outpaced our expectations and drove TiO2 and zircon volume growth versus prior quarter and prior year. Pricing was largely in line with our expectations and consistent with our margin stability program. TiO2 revenues increased 8% versus a year ago quarter and 17% versus the prior quarter as sales volumes improved 18% in both comparisons. The volume increase was driven by both organic demand and restocking, which we saw across all regions with a higher recovery rate in Europe, Middle East, Africa, and Latin America where volumes declined more notably in the past 6 quarters. As expected, TiO pricing including mix saw 1% decrease quarter-over-quarter. Zircon volumes increased 54% sequentially. We've continued to see recovery from the trough levels of July 2023 with stronger underlying demand in Q1. Zircon pricing was level with the prior quarter. Revenue from other products decreased 26% compared to the prior quarter, driven by an opportunistic sale of ilmenite and a portion of our rare earth tailings deposit in South Africa in the fourth quarter that, as we had communicated last quarter, would not repeat. Turning the Slide 8, I will now review our operating performance for the quarter. Our adjusted EBITDA of $131 million represented 10% decline year-on-year, driven by lower average selling prices and mix and higher SG&A. This is partially offset by improved sales volumes, exchange rate tailwinds and favorable reductions in input cost from materials such as chlorine, coke, caustic soda. Additionally, we saw favorable fixed cost absorption and freight costs as compared to Q1 2023. Sequentially, adjusted EBITDA improved 39%. As we mentioned last quarter, we expected to see improvements in costs as we increased our operating rates beginning late last year and continuing into this year. Compared to Q4, production costs improved $57 million. This was comprised of $32 million relating to favorable absorption and lower cost of market charges from the higher production, $15 million from the Q4 Botlek idle facility charge due to the supplier outage that did not repeat in Q1 and $10 million for lower mining costs primarily from Atlas. By the end of the year we expect to recover approximately $15 million from insurance claims relating to the downtime at Botlek due to the supplier outage. The TiO2 and zircon volume benefit to EBITDA was partially offset by the non-repeating opportunistic sale of ilmenite and a portion of our rare earth tailings deposit in Q4. Other headwinds versus the prior quarter as expected were price mix, FX, freight costs from the Red Sea impact and higher SG&A. Turning to Slide 9, I will now review our balance sheet and cash position. We ended the quarter with total debt of $2.8 billion and net debt of $2.7 billion. Our net leverage at the end of March was 5.2x on a trailing 12-month basis. Our balance sheet remains strong with ample liquidity ahead of anticipated critical vertically integrated -- integration-related capital expenditures. As John mentioned, we successfully completed a repricing transaction on 2 of our existing term loan tranches, which will result in approximately $5 million of annualized interest expense savings. We also extended the maturity of one of these tranches to 2029. Our nearest term significant maturity remains 2028 and we have no financial covenants on our term loans or bonds. Our weighted average interest rate in Q1 was 6.5%. We maintained interest rate swaps such that approximately 73% of our interest rates are fixed through 2024 and approximately 64% are fixed from 2024 through 2028, aligning with the maturity of our earliest tranche of our term loan. Total available liquidity as of March 31st was $629 million, including $152 million in cash and cash equivalents that are well distributed across the globe. Capital expenditures totaled $76 million in the quarter. Roughly 44% of this was for maintenance and safety and 56% was for strategic growth projects. Working capital was a use of $127 million in the quarter. The massive majority of this, which related to higher revenue driving an increase in accounts receivable. For inventory, we would normally expect to see an increase in the first quarter in preparation for the spring coating season. While we did plan for the upturn by running at the higher production rates, the increased demand across our business resulted in inventorying being a source of cash for the quarter. Accounts payable was a decrease, which is typical of our Q1 profile. We declared a dividend of $0.50 per share on an annualized basis in the first quarter that was paid to shareholders in the second quarter. I will now turn the call back over to John Romano for some comments on the year ahead and our outlook. John?